Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Antonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, Simona Gaudino, Rosalinda Calandrelli, Ciro Mazzarella, Carmelo Caldarella, Mario Rigante, Marco Gessi, Liverana Lauretti, Laura De Marinis, Alessandro Olivi, Alfredo Pontecorvi & Francesco Doglietto. (2023) Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors. Frontiers in Endocrinology 14.
Crossref
Crossref
Atsushi Ishida, Hiroki Shichi, Hidenori Fukuoka, Hideki Shiramizu, Naoko Inoshita & Shozo Yamada. (2022) Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review. Frontiers in Oncology 12.
Crossref
Crossref
George Kontogeorgos, Eleni Thodou, Robert Y. Osamura & Ricardo V. Lloyd. (2022) High-risk pituitary adenomas and strategies for predicting response to treatment. Hormones 21:1, pages 1-14.
Crossref
Crossref
Fernando Guerrero-Pérez, Agustina Pia Marengo, Noemi Vidal & Carles Villabona. (2020) Pituitary Adenomas with Changing Phenotype: A Systematic
Review. Experimental and Clinical Endocrinology & Diabetes 128:12, pages 835-844.
Crossref
Crossref
Pedro Iglesias, Rosa Magallón, Mercedes Mitjavila, Víctor Rodríguez Berrocal, Héctor Pian & Juan J. Díez. (2020) Multimodal therapy in aggressive pituitary tumors. Endocrinología, Diabetes y Nutrición 67:7, pages 469-485.
Crossref
Crossref
Pedro Iglesias, Rosa Magallón, Mercedes Mitjavila, Víctor Rodríguez Berrocal, Héctor Pian & Juan J. Díez. (2020) Multimodal therapy in aggressive pituitary tumors. Endocrinología, Diabetes y Nutrición (English ed.) 67:7, pages 469-485.
Crossref
Crossref
Jacqueline Trouillas, Alexandre Vasiljevic, Marion Lapoirie, Laura Chinezu, Emmanuel Jouanneau & Gérald Raverot. (2019) Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment. Minerva Endocrinologica 44:2.
Crossref
Crossref
Mario Giordano, Amir Samii & Rudolf Fahlbusch. (2017) Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management. Neurosurgical Review 41:4, pages 999-1005.
Crossref
Crossref
Alexander S. G. Micko, Romana Höftberger, Adelheid Wöhrer, Matthias Millesi, Engelbert Knosp & Stefan Wolfsberger. (2018) MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals. Pituitary 21:3, pages 266-273.
Crossref
Crossref
Fabienne Langlois, Randall Woltjer, Justin S. Cetas & Maria Fleseriu. (2018) Silent somatotroph pituitary adenomas: an update. Pituitary 21:2, pages 194-202.
Crossref
Crossref
Sylvia L. Asa & Shereen Ezzat. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Fabienne Langlois, Dawn Shao Ting Lim, Elena Varlamov, Chris G. Yedinak, Justin S. Cetas, Shirley McCartney, Aclan Dogan & Maria Fleseriu. (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58:3, pages 528-534.
Crossref
Crossref
Sauradeep Sarkar, Vinu Joe Philip, Sai Kiran Cherukuri, Ari George Chacko & Geeta Chacko. (2017) Implications of the World Health Organization definition of atypia on surgically treated functional and non-functional pituitary adenomas. Acta Neurochirurgica 159:11, pages 2179-2186.
Crossref
Crossref
Anna Angelousi, Georgios K Dimitriadis, Georgios Zografos, Svenja Nölting, Gregory Kaltsas & Ashley Grossman. (2017) Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocrine-Related Cancer 24:6, pages R239-R259.
Crossref
Crossref
Hélène Lasolle, Christine Cortet, Fréderic Castinetti, Lucie Cloix, Philippe Caron, Brigitte Delemer, Rachel Desailloud, Christel Jublanc, Christine Lebrun-Frenay, Jean-Louis Sadoul, Luc Taillandier, Marie Batisse-Lignier, Fabrice Bonnet, Nathalie Bourcigaux, Damien Bresson, Olivier Chabre, Philippe Chanson, Cyril Garcia, Magalie Haissaguerre, Yves Reznik, Sophie Borot, Chiara Villa, Alexandre Vasiljevic, Stephan Gaillard, Emmanuel Jouanneau, Guillaume Assié & Gérald Raverot. (2017) Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. European Journal of Endocrinology 176:6, pages 769-777.
Crossref
Crossref
Laura Chinezu, Alexandre Vasiljevic, Jacqueline Trouillas, Marion Lapoirie, Emmanuel Jouanneau & Gérald Raverot. (2017) Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature. European Journal of Endocrinology 176:2, pages 195-201.
Crossref
Crossref
Ravikar Ralph, Riddhi Das Gupta, Ari G. Chacko, Geeta Chacko & Nihal Thomas. (2017) Growth Hormone–Secreting Pituitary Carcinoma Presenting With Isolated Leptomeningeal Involvement: A Challenging Diagnosis. AACE Clinical Case Reports 3:1, pages e12-e16.
Crossref
Crossref
Alissa A. Thomas & Camilo E. Fadul. 2017. Transsphenoidal Surgery. Transsphenoidal Surgery
581
594
.
Yan JiRachel Isaksson VogelEmil Lou. (2016) Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports. Neuro-Oncology Practice 3:3, pages 188-195.
Crossref
Crossref
James K. Liu, Jimmy Patel & Jean Anderson Eloy. (2015) The role of temozolomide in the treatment of aggressive pituitary tumors. Journal of Clinical Neuroscience 22:6, pages 923-929.
Crossref
Crossref
Ali A Ghazi, Fabio Rotondo, Kalman Kovacs, Alireza Amirbaigloo, Luis V Syro, Hussein Fathalla, Antonio Di Ieva & Michael D. Cusimano. (2015) Treatment of Invasive Silent Somatotroph Pituitary Adenoma with Temozolomide. Report of a Case and Review of the Literature. Endocrine Pathology 26:2, pages 135-139.
Crossref
Crossref
Oscar D. Bruno, Lea Juárez-Allen, Silvia B. Christiansen, Marcos Manavela, Karina Danilowicz, Carlos Vigovich & Reynaldo M. Gómez. (2015) Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina. International Journal of Endocrinology 2015, pages 1-8.
Crossref
Crossref
Javier Aller Pardo, Mariana Campderá Michelena, Nuria Palacios García & Javier Estrada García. 2015. Actualización en neuroendocrinología. Actualización en neuroendocrinología
171
198
.
Antonio Di Ieva, Fabio Rotondo, Luis V. Syro, Michael D. Cusimano & Kalman Kovacs. (2014) Aggressive pituitary adenomas—diagnosis and emerging treatments. Nature Reviews Endocrinology 10:7, pages 423-435.
Crossref
Crossref
Jacqueline Trouillas. (2014) In Search of a Prognostic Classification of Endocrine Pituitary Tumors. Endocrine Pathology 25:2, pages 124-132.
Crossref
Crossref
Anthony Heaney. (2014) Management of aggressive pituitary adenomas and pituitary carcinomas. Journal of Neuro-Oncology 117:3, pages 459-468.
Crossref
Crossref
Gerald Raverot, Emmanuel Jouanneau & Jacqueline Trouillas. (2014) MANAGEMENT OF ENDOCRINE DISEASE: Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. European Journal of Endocrinology 170:4, pages R121-R132.
Crossref
Crossref
Akira Matsuno, Mineko Murakami, Katsumi Hoya, Shoko M. Yamada, Shinya Miyamoto, So Yamada, Jae-Hyun Son, Hajime Nishido, Fuyuaki Ide, Hiroshi Nagashima, Mutsumi Sugaya, Toshio Hirohata, Akiko Mizutani, Hiroko Okinaga, Yudo Ishii, Shigeyuki Tahara, Akira Teramoto & R. Yoshiyuki Osamura. (2013) Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Medical Molecular Morphology 47:1, pages 1-7.
Crossref
Crossref
Marianne Andersen. (2014) MANAGEMENT OF ENDOCRINE DISEASE: GH excess: diagnosis and medical therapy. European Journal of Endocrinology 170:1, pages R31-R41.
Crossref
Crossref
Laura Chinezu, Emmanuel Jouanneau, Alexandre Vasiljevic, Jacqueline Trouillas & Gérald Raverot. (2013) Silent GH pituitary tumor: Diagnostic and therapeutic challenges. Annales d'Endocrinologie 74:5-6, pages 491-495.
Crossref
Crossref